Zymeworks Inc. (ZYME) stock chart
ZYMENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30141% above fair value
$29.07−2.39 (-7.60%)
Close on Nov 11, 2026Market cap $2.06BP/E 55.9Yield –
Daily, weekly, monthly, quarterly and yearly candles from end-of-day prices, adjusted for splits. Marks along the bottom: E for earnings, D for ex-dividend dates, S for stock splits. Drawings are saved in this browser for each symbol; indicators and chart settings carry across symbols.
See a number that looks wrong?